Clarithromycin (9E)-O-Methyloxime is a derivative of the macrolide antibiotic clarithromycin, modified with a methyloxime group at the 9-position in the E-configuration. This compound is primarily used as a reference standard or impurity marker in pharmaceutical research and quality control for clarithromycin-related products.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 127182-44-9
Clarithromycin oxime
pharmaceutical intermediate
Clarithromycin
pharmaceutical raw material
Erythromycin oxime
pharmaceutical raw material
(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-10-hydroxyimino-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
pharmaceutical raw material
(1R,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol
Impurity of Doxercalciferol
(1r,3s)-3-aminocyclopentanol hydrochloride
pharmaceutical intermediate
Ibrutinib acetyl impurity
pharmaceutical impurity standard
N,N'-bis(5-benzoyl-1H,-benzimidazol-2-yl)urea
pharmaceutical intermediate
(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-10-methoxyimino-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one
BZXVFUGKJGEBBE-HQQTWTRQSA-N
CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O